Bright Rock Capital Management LLC Takes Position in Morgan Stanley $MS

Bright Rock Capital Management LLC acquired a new position in Morgan Stanley (NYSE:MS) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 16,000 shares of the financial services provider’s stock, valued at approximately $2,840,000.

A number of other large investors have also recently made changes to their positions in MS. Olistico Wealth LLC purchased a new position in Morgan Stanley during the fourth quarter valued at approximately $27,000. WFA of San Diego LLC bought a new position in Morgan Stanley in the second quarter valued at $28,000. Greykasell Wealth Strategies Inc. raised its holdings in shares of Morgan Stanley by 65.2% during the 3rd quarter. Greykasell Wealth Strategies Inc. now owns 185 shares of the financial services provider’s stock valued at $29,000 after buying an additional 73 shares in the last quarter. Family Legacy Financial Solutions LLC raised its stake in shares of Morgan Stanley by 91.9% during the third quarter. Family Legacy Financial Solutions LLC now owns 213 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 102 shares in the last quarter. Finally, Strive Asset Management LLC purchased a new position in Morgan Stanley in the 3rd quarter worth $34,000. 84.19% of the stock is owned by institutional investors.

Trending Headlines about Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: Morgan Stanley priced a low‑fee spot Bitcoin ETF (record‑low fee reported), signalling a competitive push into digital‑asset distribution that could win advisor flows and AUM over time — positive for future fee income and market positioning. Morgan Stanley’s Bitcoin ETF Push Recasts Its Digital Asset Ambitions
• Positive Sentiment: Research franchise boosting client engagement: Morgan Stanley elevated Meta to a top pick and highlighted AI/security winners (Microsoft, CrowdStrike among top AI security bets). Strong, visible research can drive advisory mandates, trading flows and investment‑banking touchpoints. ‘It’s time to buy Meta.’ Why Morgan Stanley sees 45% upside for the stock.
• Positive Sentiment: Morgan Stanley published a top‑5 AI security stock list (MSFT, CRWD highlighted), reinforcing its tech research leadership and potential deal/placement opportunities in fast‑growing cybersecurity themes. Microsoft, CrowdStrike Lead Among Morgan Stanley’s Top 5 AI Security Bets
• Neutral Sentiment: Macro positioning commentary from Morgan Stanley (S&P correction nearing an end) signals caution but also a tactical buy narrative — this guidance can temper client risk taking and influence trading and asset‑management flows in the short term. S&P 500 Selloff Is ‘Getting Closer to Its Ending Stages,’ Says Morgan Stanley
• Negative Sentiment: Reputational/regulatory risk: an FT report says a Morgan Stanley wealth manager approached BlackRock about a multimillion‑dollar defence fund tied to a senior government official — such stories can raise compliance and reputational questions for a wealth manager and could weigh on sentiment. Pete Hegseth’s broker looked to buy defence fund before Iran attack

Insider Activity at Morgan Stanley

In related news, insider Charles A. Smith sold 8,500 shares of the stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $182.08, for a total transaction of $1,547,680.00. Following the completion of the transaction, the insider directly owned 119,128 shares of the company’s stock, valued at approximately $21,690,826.24. This represents a 6.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michael A. Pizzi sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $184.55, for a total value of $3,691,000.00. Following the transaction, the insider owned 127,872 shares of the company’s stock, valued at $23,598,777.60. This represents a 13.53% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 129,191 shares of company stock worth $23,736,506 in the last three months. Corporate insiders own 0.19% of the company’s stock.

Morgan Stanley Price Performance

MS opened at $158.25 on Tuesday. Morgan Stanley has a 52-week low of $94.33 and a 52-week high of $192.68. The company has a debt-to-equity ratio of 3.39, a quick ratio of 0.81 and a current ratio of 0.81. The company’s 50-day simple moving average is $170.48 and its two-hundred day simple moving average is $169.16. The stock has a market capitalization of $251.28 billion, a P/E ratio of 15.50, a P/E/G ratio of 1.27 and a beta of 1.20.

Morgan Stanley (NYSE:MS) last issued its quarterly earnings data on Thursday, January 15th. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.28 by $0.40. The company had revenue of $17.90 billion during the quarter, compared to analyst estimates of $17.69 billion. Morgan Stanley had a return on equity of 16.78% and a net margin of 14.09%.Morgan Stanley’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.22 earnings per share. As a group, analysts predict that Morgan Stanley will post 8.56 EPS for the current year.

Morgan Stanley Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Friday, January 30th were paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Friday, January 30th. Morgan Stanley’s dividend payout ratio is presently 39.18%.

Analyst Ratings Changes

Several research analysts recently commented on MS shares. Keefe, Bruyette & Woods lifted their target price on shares of Morgan Stanley from $202.00 to $210.00 and gave the stock a “moderate buy” rating in a research note on Friday, January 16th. Wall Street Zen raised Morgan Stanley from a “hold” rating to a “buy” rating in a research report on Friday, January 23rd. Wolfe Research reissued an “outperform” rating and set a $211.00 price target on shares of Morgan Stanley in a research report on Wednesday, January 7th. BNP Paribas Exane lifted their target price on shares of Morgan Stanley from $170.00 to $195.00 in a report on Friday, January 16th. Finally, Zacks Research downgraded Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 23rd. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $187.14.

Morgan Stanley Profile

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.